Key result
Pretreatment with Panax notoginseng saponins significantly protected mice from doxorubicin-induced cardiotoxicity by improving ventricular contractile function and lowering serum cardiac injury markers.
Authors
Loading...
Should not change doxorubicin regimens in patients; leaves open saponin cardioprotection for prospective clinical trials.
Liu et al. (2008) studied Doxorubicin-induced cardiotoxicity. Panax notoginseng saponins (PNS) vs. Doxorubicin alone (20 mg/kg i.p.) was evaluated on Cardiac function, serum levels of LDH, CK, CK-MB, and antioxidant enzymes. Pretreatment with Panax notoginseng saponins significantly protected mice from doxorubicin-induced cardiotoxicity by improving ventricular contractile function and lowering serum cardiac injury markers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: